Method of treatment of hiv-seropositive individuals with...

Details Method of treatment of hiv-seropositive individuals with... Method of treatment of hiv-seropositive individuals with...

A - Human Necessities

61

K

A61K 39/395 (2006.01) A23L 1/305 (2006.01) A61K 35/20 (2006.01) A61K 38/17 (2006.01)

Patent

CA 2090186

Undenatured whey protein concentrate is administered to HIV-seropositive individuals to elevate their blood mononuclear cells, glutathione (GSH) level, body weight and sense of well being. In addition T-helper cells concentration and their T-helper cells; /T-suppressor cells ratio are slightly elevated.

Un concentré protéinique non caséique est administré à des individus VIH séropositifs pour augmenter le nombre de cellules sanguines mononucléaires, le taux de glutathione (GSH), le poids corporel et la sensation de bien-être. De plus, la concentration des lymphocytes T-4 et le rapport lymphocytes T-4/lymphocytes T-suppresseurs se trouvent légèrement augmentés.

Affiliated with

Also associated with

Rating

Method of treatment of hiv-seropositive individuals with... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treatment of hiv-seropositive individuals with..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treatment of hiv-seropositive individuals with... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1933621